IP Library Granted Patent US 11,445,978
Granted Patent B2
US 11,445,978 · App. 16/691,387 · Granted Sep 20, 2022

Stent graft monitoring assembly and method of use thereof

Inventor: William L. Hunter (Vancouver, CA)
Assignee: Canary Medical Switzerland AG
A61B5/6862A61B5/0031A61B5/01A61B5/076A61F2/07A61B5/026A61B5/0215A61B5/02158A61B5/065A61B5/145A61B5/14532A61B5/14539A61B5/14542A61B5/14546A61B2562/06A61F2230/0069
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,445,978
App. No.
16/691,387
Granted
Sep 20, 2022
Kind
B2
Abstract

Assemblies are provided for positioning within a lumen comprising a stent graft; and a sensor positioned on the stent graft. Within certain aspects the sensors are wireless sensors, and include for example one or more fluid pressure sensors, contact sensors, position sensors, pulse pressure sensors, blood volume sensors, blood flow sensors, chemistry sensors (e.g., for blood and/or other fluids), metabolic sensors (e.g., for blood and/or other fluids), mechanical stress sensors and/or temperature sensors.

Claims (33)

1. A method for monitoring cardiovascular disease in a patient, the method comprising:

a. providing the patient with a stent graft that is inserted into an aneurysm sac of an aorta of the patient, where the stent graft comprises at least one sensor;

b. making measurements with the at least one sensor according to a desired schedule of measurements times, to provide data;

c. collecting and storing the data in a memory located inside the stent graft, to provide stored data;

d. outputting the stored data to a receiving unit located outside of the patient to provide outputted data;

e. determining cardiac function from the outputted data to provide a function of a heart of the patient at a measurement time according to the schedule; and

f. monitoring cardiovascular disease from the function of the heart of the patient as determined at the measurement times.

2. The method of claim 1 wherein the stent graft comprises at least one of a sensor selected from a fluid pressure sensor, a blood volume sensor, a pulse pressure sensor, a heart rate sensor, and a blood flow sensor.

3. The method of claim 1 wherein the cardiac function comprises at least one of stroke volume and system vascular resistance information.

4. The method of claim 1 wherein the cardiac function comprises cardiac output.

5. The method of claim 1 wherein the cardiac function comprises at least one of ejection fraction and cardiac index.

6. The method of claim 1 further comprising implementing cardiac medications and dosages for the patient to address the cardiovascular disease.

7. The method of claim 1 further comprising implementing new cardiac medication and/or a new cardiac medication dosage for the patient to address the cardiovascular disease; and monitoring the response of the patient to the new cardiac medication and/or the new dosage thereof.

8. The method of claim 1 further comprising adjusting cardiac medication and/or dosage for the patient to address the cardiovascular disease.

9. The method of claim 1 further comprising adjusting cardiac medication and/or dosage for the patient to address the cardiovascular disease; and monitoring the response of the patient to the adjusted cardiac medication and/or adjusted dosage thereof.

10. The method of claim 1 wherein the cardiac function comprises cardiac arrhythmia and heart rate abnormality.

11. The method of claim 1 wherein the determining cardiac function is selected from determining at least one of cardiac output (CO), stroke volume (SV), ejection fraction (EV), systolic blood pressure (sBP), diastolic blood pressure (dBP), mean arterial pressure (mAP), systemic vascular resistance (SVR), total peripheral resistance (TPV) and pulse pressure (PP) of the patient.

12. A method for detecting bacterial infection in a patient, the method comprising:

a. providing the patient with a stent graft that is inserted into an aneurysm sac of an aorta of the patient, where the stent graft comprises at least one sensor, where at least one sensor is a temperature sensor that measures at least one of a temperature of a blood in the aorta of the patient and a temperature of a wall of the aorta;

b. making measurements with the at least one temperature sensor according to a desired schedule of measurements times, to provide temperature data;

c. collecting and storing the temperature data in a memory located inside the stent graft, to provide stored temperature data;

d. outputting the stored temperature data to a receiving unit located outside of the patient to provide outputted temperature data;

e. determining a patient temperature from the outputted data to provide a patient temperature at a measurement time according to the schedule; and

f. monitoring infection from the patient temperature as determined at each of the measurement times.

13. The method of claim 12 wherein the blood temperature of the patient increases at the measurement times, and the patient is identified as having a bacterial infection.

14. A method for detecting a blood clot in a patient, the method comprising:

a. providing the patient with a stent graft that is inserted into an aneurysm sac of an aorta of the patient, where the stent graft comprises at least one sensor, where at least one sensor is metabolic sensor or a chemistry sensor that measures a pH of a blood in the aorta of the patient;

b. making measurements with the at least one sensor according to a desired schedule of measurements times, to provide pH data;

c. collecting and storing the pH data in a memory located inside the stent graft, to provide stored pH data;

d. outputting the stored pH data to a receiving unit located outside of the patient to provide outputted pH data;

e. determining a patient blood pH from the outputted data to provide a blood pH at a measurement time according to the schedule; and

f. monitoring blood clot formation from the blood pH as determined at each of the measurement times.

15. The method of claim 14 wherein the blood pH decreases as determined at each of the measurement times, and the patient is identified as having a blood clot.

Assignments (4)
SECURITY INTEREST Recorded Mar 13, 2024
From: CANARY MEDICAL SWITZERLAND AG
To: ZIMMER BIOMET HOLDINGS, INC.
Reel/Frame 066753/0391 →
SECURITY INTEREST Recorded Mar 13, 2024
From: CANARY MEDICAL INC.; CANARY MEDICAL SWITZERLAND AG
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 066796/0443 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2022
From: CANARY MEDICAL INC.
To: CANARY MEDICAL SWITZERLAND AG
Reel/Frame 060150/0777 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2021
From: HUNTER, WILLIAM L.
To: CANARY MEDICAL INC.
Reel/Frame 055604/0360 →
Continuity (4)
Continuation 15957641 · Apr 19, 2018
Continuation 14654529
Provisional Application 61745403 · Dec 21, 2012
Related Publication 20200289060A1 · Sep 17, 2020